Thursday, 30 June, 2022

Topic: Covaxin

Health ministry claims Covaxin has WHO approval for use in under-18s, but it doesn’t

The Union health ministry’s website claims that Covaxin has received Emergency Use Listing for 15-18-year-olds, but the WHO had noted in November that this was not the case.

Over 6 lakh teens register on Co-WIN as India gets set to vaccinate 15-18 year olds

Paediatric vaccinations will begin across centres in India at 9 am. Even those who have not registered on the Co-WIN app can walk into any centre to get their jabs.

Covaxin demonstrates robust safety and immunogenicity in 2-18-year-old volunteers, study says

The data was submitted to the Central Drugs Standard Control Organisation during October 2021 and received emergency use nod for children aged 12-18 from DCGI recently.

India considers ‘mix and match’ for Covid booster shots as calls for third dose grow

No decision has been taken yet on whether booster shots will be given, even as healthcare workers who got fully vaccinated in February near 10 months of vaccination.

ZyCov-D supplies to begin soon but may not be part of national vaccine programme right away

With Omicron on the prowl and decision pending on vaccinating children, government may wait before using the one crore doses of ZyCoV-D, the only vaccine licensed for use in minors

‘Bruce Lee assault’ — ICMR official explains why Covaxin may have edge against Omicron

Dr Samiran Panda says Covaxin, being a whole virion vaccine, could work better, while there are chances of Omicron escaping targeted vaccines such as those based on the mRNA platform.

Covid expert panel’s recommendations on Covaxin for kids being examined, Modi govt informs RS

In a written reply, MoS Health Bharati Pravin Pawar said additional information has been requested at the level of Central Drugs Standard Control Organisation for the examination.

Modi govt allows commercial export of Covishield, Covaxin in view of sufficient stock

India recently resumed Covid vaccine supply to the UN-backed COVAX with the govt allowing SII to export 50 lakh doses of Covishield to Nepal, Tajikistan, Bangladesh and Mozambique.

Everyone was at risk during lockdown. But women were real superheroes in Covaxin’s journey

In 'Going Viral: Making of Covaxin', Dr Balram Bhargava unpacks the story of India's indigenous Covid-19 vaccine.

Covaxin was 50% effective among health workers in 2nd wave, real-world study from AIIMS shows

Study published in Lancet Infectious Diseases journal assessed 2,714 hospital workers from AIIMS New Delhi, who were most exposed to Covid and were primarily offered Covaxin.

On Camera


Representational image | Islam devotees offer Friday prayers during Ramadan, Patna, April 2022 | PTI

Quran says no one can limit others’ freedom. Udaipur killing violates Islam’s golden rule

Throughout history, Islamic scholars have uniformly agreed that respecting and obeying the law of the land is an essential aspect of faith.
The Reserve Bank of India logo | Photo: Suraj Singh Bisht | ThePrint

RBI intervenes with multi-pronged strategy in battle against rupee fall

The Reserve Bank’s challenges include crashes in forward dollar premiums to rising open interest in futures that adds to pressure on the currency.


The Indian Air Force logo | Commons

Almost 4,000 enrol for IAF’s Agnipath recruitment scheme on day 1 of online registrations

These registrations pertain to the Indian Air Force's Agniveer Vayu programme. The online portal for the first phase was opened at 10 am Friday, and will close on 5 July.

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Modi govt's biggest flaw has been its disinclination to accept limitations of electoral majorities. This ruined land acquisition and farm reform, stalled labour codes.